These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11830459)

  • 1. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns.
    Streiff MB; Smith B; Spivak JL
    Blood; 2002 Feb; 99(4):1144-9. PubMed ID: 11830459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options for essential thrombocythemia and polycythemia vera.
    Solberg LA
    Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Polycythemia Vera: A Survey of Canadian Physician Practice Patterns.
    Habib LA; Kuo KHM; Panzarella T; Gupta V; Trinkaus M
    Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e37-e42. PubMed ID: 30322792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and treatment of polycythemia vera patients in clinical practice: a multicenter chart review on 1476 individuals in Germany.
    Jentsch-Ullrich K; Eberhardt J; Zeremski V; Koehler M; Wolleschak D; Heidel FH
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2041-9. PubMed ID: 27431664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycythemia Vera.
    Spivak JL
    Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice Patterns in the Diagnosis and Treatment of Polycythemia Vera in the Post-JAK2 V617F Discovery Era.
    Kander EM; Moliterno AR; Rademaker A; Streiff MB; Spivak JL; Stein BL
    J Natl Compr Canc Netw; 2016 Oct; 14(10):1238-1245. PubMed ID: 27697978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic progressive polycythemia and thrombocytosis].
    Forkert R; Ko Y; Fronhoffs S; Tschubel K; Vetter H
    Praxis (Bern 1994); 2001 Apr; 90(17):741-6. PubMed ID: 11387815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mail survey of United States hematologists and oncologists: a comparison of business reply versus stamped return envelopes.
    Streiff MB; Dundes L; Spivak JL
    J Clin Epidemiol; 2001 Apr; 54(4):430-2. PubMed ID: 11297894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to manage polycythemia vera.
    Passamonti F
    Leukemia; 2012 May; 26(5):870-4. PubMed ID: 22157736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
    Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
    Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.
    Ruggeri M; Tosetto A; Frezzato M; Rodeghiero F
    Ann Intern Med; 2003 Sep; 139(6):470-5. PubMed ID: 13679323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists.
    Andreasson B; Löfvenberg E; Westin J
    Eur J Haematol; 2005 Jun; 74(6):489-95. PubMed ID: 15876252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of diagnostic criteria in polycythemia vera.
    Pearson TC
    Semin Hematol; 2001 Jan; 38(1 Suppl 2):21-4. PubMed ID: 11242598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inapparent polycythemia vera: an unrecognized diagnosis.
    Lamy T; Devillers A; Bernard M; Moisan A; Grulois I; Drenou B; Amiot L; Fauchet R; Le Prise PY
    Am J Med; 1997 Jan; 102(1):14-20. PubMed ID: 9209196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of early diagnosis in polycythemia vera and essential thrombocythemia: A single center's experience.
    Lakhwani S; Pardina-Echevarría M; Arcas-Vega R; Díaz-Sánchez OR; Hernández-García MT; Raya JM
    Rev Clin Esp (Barc); 2022 Mar; 222(3):169-173. PubMed ID: 34657827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.
    Barbui T; Passamonti F; Accorsi P; Pane F; Vannucchi AM; Velati C; Gale RP; Tura S; Barosi G
    Leukemia; 2018 Sep; 32(9):2077-2081. PubMed ID: 29955128
    [No Abstract]   [Full Text] [Related]  

  • 20. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.